Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomasz Kolenda

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Contemporary Oncology (Poznan, Poland)|May 4, 2022
Oxidative stress in melanogenesis and melanoma developmentKacper Kamiński, Urszula Kazimierczak, Tomasz Kolenda
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 5, 2024
Impact of ramipril nitroso-metabolites on cancer incidence - in silico and in vitro safety evaluationKatarzyna Regulska, Tomasz Kolenda, Marcin Michalak, et al.
Heliyon|April 11, 2024
Diagnostic and prognostic role of long non-coding RNAs (lncRNAs) in metastatic melanoma patients with BRAF gene mutation receiving BRAF and MEK inhibitorsŁukasz Galus, Tomasz Kolenda, Michał Michalak, et al.
Cells|June 26, 2024
Targeting the Hippo Pathway in Cutaneous MelanomaUrszula Kazimierczak, Anna Przybyla, Marianna Smielowska, et al.
Journal of Biomedical Science|February 14, 2019
Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcomeTomasz Kolenda, Kacper Guglas, Anna Teresiak, et al.
Anticancer Research|July 5, 2020
BNIP3L Is a New Autophagy Related Prognostic Biomarker for Melanoma Patients Treated With AGI-101HUrszula Kazimierczak, Tomasz Kolenda, Dariusz Kowalczyk, et al.
Contemporary Oncology (Poznan, Poland)|December 6, 2014
The mystery of let-7d - a small RNA with great powerTomasz Kolenda, Weronika Przybyła, Anna Teresiak, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 5, 2024
miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncologyJoanna Kozłowska-Masłoń, Kacper Guglas, Tomasz Kolenda, et al.
International Journal of Molecular Sciences|April 3, 2021
LATS1 Is a Mediator of Melanogenesis in Response to Oxidative Stress and Regulator of Melanoma GrowthUrszula Kazimierczak, Ewelina Dondajewska, Maria Zajaczkowska, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 11, 2018
Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and NeckIzabela Łasińska, Tomasz Kolenda, Anna Teresiak, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Contemporary Oncology (Poznan, Poland)|May 4, 2022
Oxidative stress in melanogenesis and melanoma developmentKacper Kamiński, Urszula Kazimierczak, Tomasz Kolenda
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 5, 2024
Impact of ramipril nitroso-metabolites on cancer incidence - in silico and in vitro safety evaluationKatarzyna Regulska, Tomasz Kolenda, Marcin Michalak, et al.
Heliyon|April 11, 2024
Diagnostic and prognostic role of long non-coding RNAs (lncRNAs) in metastatic melanoma patients with BRAF gene mutation receiving BRAF and MEK inhibitorsŁukasz Galus, Tomasz Kolenda, Michał Michalak, et al.
Cells|June 26, 2024
Targeting the Hippo Pathway in Cutaneous MelanomaUrszula Kazimierczak, Anna Przybyla, Marianna Smielowska, et al.
Journal of Biomedical Science|February 14, 2019
Low let-7d and high miR-205 expression levels positively influence HNSCC patient outcomeTomasz Kolenda, Kacper Guglas, Anna Teresiak, et al.
Anticancer Research|July 5, 2020
BNIP3L Is a New Autophagy Related Prognostic Biomarker for Melanoma Patients Treated With AGI-101HUrszula Kazimierczak, Tomasz Kolenda, Dariusz Kowalczyk, et al.
Contemporary Oncology (Poznan, Poland)|December 6, 2014
The mystery of let-7d - a small RNA with great powerTomasz Kolenda, Weronika Przybyła, Anna Teresiak, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|January 5, 2024
miRNA in head and neck squamous cell carcinomas: promising but still distant future of personalized oncologyJoanna Kozłowska-Masłoń, Kacper Guglas, Tomasz Kolenda, et al.
International Journal of Molecular Sciences|April 3, 2021
LATS1 Is a Mediator of Melanogenesis in Response to Oxidative Stress and Regulator of Melanoma GrowthUrszula Kazimierczak, Ewelina Dondajewska, Maria Zajaczkowska, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 11, 2018
Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and NeckIzabela Łasińska, Tomasz Kolenda, Anna Teresiak, et al.
Pageof 7